Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Millennium and Aventis initiate major strategic alliance

Aug. 1, 2000

Rat studies support Cereport as an effective means of enhancing carboplatin delivery

July 31, 2000

CIMA licenses DuraSolv dosage form to Schwarz

July 27, 2000

Schein licenses ML Laboratories' Clickhaler in Canada

July 27, 2000

Substance from spider venom is first to block stretch-activated channels

July 24, 2000

Pharmacopeia identifies active compounds in lead discovery program with Roche Bioscience

July 19, 2000

Pharmacopeia achieves milestone in Organon collaboration

July 17, 2000

SkyePharma and Kirin Brewery enter drug delivery contract

July 17, 2000

Agents useful for transferring nucleic acids into cells patented by Aventis

July 14, 2000

Abgenix and Lexicon Genetics establish antibody drug discovery alliance

July 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...